| Tyyppi : |
Lehti |
| Internet-yhteys : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=4255 |
|
| Tutkimus Joukkueet : |
Aurora - Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado |
| Tekijät : |
Larson B L, Bushman L R, Casciano M L, Oldland A R, Kiser J J, Kiser T H. |
| Otsikko : |
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature. |
| Numero : |
Int J Pharm Compound ; 20, 6 : 521-525. 2016 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Ribavirine
|
 |
 |
 |
 |
2000 mg
Virazole® |
|
- 20°C |
 |
| 45 |
 |
|
|
|
|
|
2000 mg
Virazole® |
|
25°C |
 |
| 45 |
|
|
|
|
|
|
2000 mg
Virazole® |
|
4°C |
|
| 45 |
|
|
|
|
 |
|
2000 mg
Virazole® |
|
- 20°C |
|
| 45 |
|
|
|
|
|
|
2000 mg
Virazole® |
|
25°C |
|
| 45 |
|
|
|
|
|
|
2000 mg
Virazole® |
|
4°C |
|
| 45 |
|
|
|
|
|
